...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan.
【24h】

Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan.

机译:化学栓塞负载珠的比较研究:负载阿霉素和伊立替康的DC珠和肝球的体外药物释放和物理特性。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To characterize in vitro the loadability, physical properties, and release of irinotecan and doxorubicin from two commercially available embolization microspheres. MATERIALS AND METHODS: DC Bead (500-700 microm) and Hepasphere (400-600 microm) microspheres were loaded with either doxorubicin or irinotecan solutions. Drug amount was quantified with spectrophotometry, bead elasticity was measured under compression, and bead size and loading homogeneity were assessed with microscopy image analysis. Drug release was measured over 1-week periods in saline by using a pharmacopeia flow-through method. RESULTS: Almost complete drug loading was obtained for both microsphere types and drugs. Doxorubicin-loaded DC Beads maintained their spherical shape throughout the release. In contrast, Hepaspheres showed less homogeneous doxorubicin loading and, after release, some fractured microspheres. Incomplete doxorubicin release was observed in saline over 1 week (27% +/- 2 for DC beads and 18% +/- 7 for Hepaspheres; P = .013). About 75% of this amount was released within 2.2 hours for both beads. For irinotecan, complete release was obtained for both types of beads, in a sustained manner over 2-3 hours for DC Beads, and in a significantly faster manner as a 7-minute burst for Hepaspheres. CONCLUSIONS: The two drug-eluting microspheres could be efficiently loaded with both drugs. Incomplete doxorubicin release was attributed to strong drug-bead ionic interactions. Weaker interactions were observed with irinotecan, which led to faster drug release.
机译:目的:在体外表征伊立替康和阿霉素从两种市售栓塞微球的负载能力,物理性质和释放。材料与方法:将DC珠(500-700微米)和Hepasphere(400-600微米)微球装载阿霉素或伊立替康溶液。用分光光度法对药物量进行定量,在压缩下测量珠子的弹性,并通过显微镜图像分析评估珠子的大小和负载均匀性。使用药典流通法在盐水中1周内测量药物释放。结果:微球类型和药物都获得了几乎完整的药物负载。装载阿霉素的DC微珠在整个释放过程中保持其球形。相反,肝球显示较少的均匀阿霉素负荷,释放后破裂的微球有些破裂。 1周内在盐水中观察到阿霉素释放不完全(DC磁珠为27%+/- 2,肝球为18%+/- 7; P = .013)。两个珠粒在2.2小时内释放了该量的约75%。对于伊立替康而言,两种珠子均获得了完全释放,对于DC珠子而言,持续时间超过2-3小时,而对于Hepaspheres,其显着更快地爆发了7分钟。结论:两种药物洗脱微球均可以有效负载两种药物。阿霉素释放不完全归因于强烈的药物-珠离子相互作用。与伊立替康观察到较弱的相互作用,这导致更快的药物释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号